| 臺大學術典藏 |
2018-09-10T04:04:33Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu, C.;Huang, C.-L.;Hsu, H.-C.;Lee, P.-H.;Wang, S.-J.;Cheng, A.-L.; PO-HUANG LEE; ANN-LII CHENG |
| 國立臺灣大學 |
2002 |
Her-2/Neu Overexpression Is Rare in Hepatocellular Carcinoma and Not Predictive of Anti-Her-2/Neu Regulation of Cell Growth and Chemosensitivity
|
許駿; 許輝吉; 鄭安理; HSU, CHIUN; HSU, HEY-CHI; CHENG, ANN-LII |
| 臺大學術典藏 |
2020-04-10T12:51:31Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Chiun Hsu;Huang C.-L.;Hsu H.-C.;Lee P.-H.;Wang S.-J.;Cheng A.-L.; Chiun Hsu; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; Cheng A.-L. |
| 臺大學術典藏 |
2021-09-01T02:02:28Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Hsu C.; Huang C.-L.; Hsu H.-C.; Lee P.-H.; Wang S.-J.; ANN-LII CHENG |
| 臺大學術典藏 |
2020-11-19T03:43:04Z |
HER-2/neu overexpression is rare in hepatocellular carcinoma and not predictive of anti-HER-2/neu regulation of cell growth and chemosensitivity
|
Huang C.-L.; Hsu H.-C.; PO-HUANG LEE; Wang S.-J.; Cheng A.-L.; Hsu C.; Hsu C.;Huang C.-L.;Hsu H.-C.;Po-Huang Lee;Wang S.-J.;Cheng A.-L. |
| 國立成功大學 |
2007-04-27 |
HER-2/neu raises SHP-2, stops IFN-gamma anti-proliferation in bladder cancer
|
Su, Wen-Pin; Tu, I-Hwi; Hu, Shiao-Wen; Yeh, Hsuan-Heng; Shieh, Dar-Bin; Chen, Tsai-Yun; Su, Wu-Chou |
| 國立成功大學 |
2006-02-24 |
HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion
|
Hsu, Ming-Chuan; Chang, Hui-Chiu; Hung, Wen-Chun |
| 國立中山大學 |
2006 |
HER-2/neu represses the metastasis suppressor RECK via ERK and Sp transcription factors to promote cell invasion
|
M.C. Hsu;H.C. Chang;W.C. Hung |
| 國立成功大學 |
2007-09 |
HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells
|
Hsu, Ming-Chuan; Chang, Hui-Chiu; Hung, Wen-Chun |
| 國立中山大學 |
2007 |
HER-2/neu transcriptionally activates Jab1 expression via the AKT/beta-catenin pathway in breast cancer cells
|
M.C. Hsu;H.C. Chang;W.C. Hung |
| 高雄醫學大學 |
2001 |
Her-2/neu 腫瘤蛋白在家族性及非家族性乳癌的表現
|
蔡坤寶;侯明鋒;林相如;蔡志仁;劉景勳;黃宗人 ; Kun-Bow Tsai;Ming-Feng Hou;Hsiang-Ju Lin;Chee-Yin Chai;Chiang-Shin Liu;Tsung-Jen Huang |
| 中國醫藥大學 |
2011-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 中國醫藥大學 |
2010-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 中國醫藥大學 |
2009-07-31 |
HER-2核易位與癌細胞對EGFR抑制劑產生耐藥性之探討
|
黃偉謙(Wei-Chien Huang); 洪明奇(Mien-Chie Hung) |
| 國家衛生研究院 |
2023-03 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
Chen, PC;Yeh, YM;Chu, CT;Su, PF;Chiu, PH;Lin, BW;Chen, SH;Lin, PC;Lee, CT;Chen, HHW;Chen, CC |
| 國立成功大學 |
2023-3 |
HER2 amplification in colorectal cancer with brain metastasis: A propensity score matching study
|
葉裕民; YEH, YU-MIN; Chen, Po-Chuan;Yeh, Yu-Min;Chu, Chun-Ting;Su, Pei-Fang;Chiu, Pin-Hsuan;Lin, Bo-Wen;Chen, Shang-Hung;Lin, Peng-Chan;Lee, Chung-Ta;Chen, Helen H.W.;Chen, Chien-Chin |
| 臺大學術典藏 |
2022-04-14T23:27:49Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan, Ryan Shea Ying Cong; Ong, Whee Sze; Lee, Kyung Hun; Lim, Abner Herbert; Park, Seri; Park, Yeon Hee; CHING-HUNG LIN; YEN-SHEN LU; Ono, Makiko; Ueno, Takayuki; Naito, Yoichi; Onishi, Tatsuya; Lim, Geok Hoon; Tan, Su Ming; Lee, Han Byoel; Ryu, Han Suk; Han, Wonshik; Tan, Veronique Kiak Mien; Wong, Fuh Yong; Im, Seock Ah; Tan, Puay Hoon; Chan, Jason Yongsheng; Yap, Yoon Sim |
| 臺大學術典藏 |
2022-05-11T08:25:41Z |
HER2 expression, copy number variation and survival outcomes in HER2-low non-metastatic breast cancer: an international multicentre cohort study and TCGA-METABRIC analysis
|
Tan R.S.Y.C.; Ong W.S.; Lee K.-H.; Lim A.H.; Park S.; Park Y.H.; CHING-HUNG LIN; Lu Y.-S.; Ono M.; Ueno T.; Naito Y.; Onishi T.; Lim G.-H.; Tan S.-M.; Lee H.-B.; Ryu H.S.; Han W.; Tan V.K.M.; Wong F.-Y.; Im S.-A.; Tan P.H.; Chan J.Y.; Yap Y.-S. |
| 中山醫學大學 |
2010 |
HER2 gene amplification in primary mucinous ovarian cancer: a potential therapeutic target.
|
Han, CP; Hsu, JD; Yao, CC; Lee, MY; Ruan, A; Tyan, YS; Yang, SF; Chiang, H |
| 高雄醫學大學 |
2006 |
HER2 I655V 多形異化Val攜帶者基因型是台灣乳癌早發危險因子
|
侯明鋒;謝佩真;歐陽賦;陳芳銘;王照元;謝建勳;黃裕勝;黃哲人;黃宗人;侯孟君;侯乃文;蔡世盟;蔡麗玉 |
| 高雄醫學大學 |
2006 |
HER2 I655V 多形異化Val攜帶者基因型是台灣乳癌早發危險因子
|
侯明鋒;謝佩真;歐陽賦;陳芳銘;王照元;謝建勳;黃裕勝;黃哲人;黃宗人;侯孟君;侯乃文;蔡世盟;蔡麗玉 |
| 國家衛生研究院 |
2015-05 |
HER2 testing in breast cancer by quantitative PCR: Technical and clinical considerations
|
Yu, R;Chen, WC;Chiu, KY;Lu, S;Liu, YC;Ko, HY;Wu, HC;Hsieh, WC;Lee, ZJ;Zhang, P;Shi, LL;Liu, M;Chang, KC;Su, IJ;Su, P;Yeh, YM |
| 中國醫藥大學 |
2015-05-03 |
HER2 upregulates PD-L1 expression through PI3K-Akt pathway
|
施志諭(Chih-Yu Shih);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 中國醫藥大學 |
2019-08-23 |
HER2/EZH2/GOT2在乳癌細胞中調控腫瘤惡化之角色探討
|
葉屹倫;Yi-Lun Ye |
| 中山醫學大學 |
2015 |
HER2及其相關路徑在黏液性卵巢癌的相關研究
|
趙婉如; Chao, Wan-Ru |
